Table of Contents
Tables 5-59: Orange
Tables 5-61: Parke
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 1999 | 1995 - 1999 | 1999 | 1995 - 1999 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All sites | 46 | 452.0 | 233 | 470.0 | 16 | 173.4** | 119 | 249.5 |
| Esophagus | * | # | 5 | 9.5** | * | # | 6 | 12.8** |
| Stomach | * | # | 3 | # | * | # | 1 | # |
| Colon excluding Rectum | 8 | 70.1** | 15 | 30.0** | * | # | 7 | 15.0** |
| Rectum and Rectosigmoid Junction | * | # | 13 | 27.0** | * | # | 3 | # |
| Liver | * | # | 0 | # | * | # | 3 | # |
| Pancreas | * | # | 4 | # | * | # | 4 | # |
| Lung and Bronchus | 15 | 153.4** | 62 | 122.8 | 6 | 64.5** | 56 | 116.0 |
| Melanoma of the Skin | * | # | 6 | 10.4** | * | # | 1 | # |
| Prostate | 8 | 84.5** | 48 | 99.7 | * | # | 10 | 22.4** |
| Urinary Bladder | * | # | 16 | 31.9** | * | # | 3 | # |
| Kidney and Renal Pelvis | * | # | 8 | 14.8** | * | # | 3 | # |
| Brain | * | # | 0 | # | * | # | 2 | # |
| Non-Hodgkins Lymphoma | * | # | 17 | 33.9** | * | # | 6 | 12.8** |
| Myeloma | * | # | 4 | # | * | # | 3 | # |
| Leukemia | * | # | 5 | 9.4** | * | # | 1 | # |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 1999 | 1995 - 1999 | 1999 | 1995 - 1999 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All sites | 45 | 395.3 | 205 | 370.9 | 16 | 140.7** | 83 | 144.3 |
| Colon excluding Rectum | * | # | 19 | 32.1** | * | # | 6 | 9.9** |
| Rectum and Rectosigmoid Junction | * | # | 8 | 14.5** | * | # | 0 | # |
| Liver | * | # | 1 | # | * | # | 2 | # |
| Pancreas | * | # | 4 | # | * | # | 4 | # |
| Lung and Bronchus | 6 | 50.8** | 23 | 41.1 | * | # | 23 | 40.8 |
| Melanoma of the Skin | * | # | 10 | 18.5** | * | # | 1 | # |
| Breast | 12 | 105.8** | 50 | 93.1 | * | # | 11 | 19.5** |
| Cervix Uteri | * | # | 3 | # | * | # | 0 | # |
| Corpus Uteri | * | # | 16 | 29.4** | * | # | 1 | # |
| Ovary | * | # | 8 | 14.7** | * | # | 8 | 14.4** |
| Urinary Bladder | * | # | 3 | # | * | # | 1 | # |
| Kidney and Renal Pelvis | * | # | 7 | 13.1** | * | # | 2 | # |
| Brain | * | # | 2 | # | * | # | 2 | # |
| Non-Hodgkins Lymphoma | * | # | 8 | 14.3** | * | # | 4 | # |
| Myeloma | * | # | 6 | 10.8** | * | # | 1 | # |
| Leukemia | * | # | 10 | 17.8** | * | # | 7 | 11.5** |
Rates are per 100,000; Age-adjusted, 2000 U.S. Standard Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, March 2003